Scilight Press

Author Information

Published: 04 Mar 2025

References 

• 1.
  Martinotti, G.; Vita, A.; Fagiolini, A.; et al. Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study). J. Affect. Disord. 2022, 319, 646–654. https://doi.org/10.1016/j.jad.2022.09.043.
• 2.
  Johansen, L.; Liknaitzky, P.; Nedeljkovic, M.; et al. How psychedelic-assisted therapy works for depression: Expert views and practical implications from an exploratory Delphi study. Front. Psychiatry 2023, 14, 1265910. https://doi.org/10.3389/fpsyt.2023.1265910.
• 3.
  Perkins, D.; Sarris, J.; Rossell, S.; et al. Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm. Aust. N. Z. J. Psychiatry 2021, 55, 1127–1133. https://doi.org/10.1177/0004867421998785.
• 4.
  Lima-Ojeda, J.M.; Rupprecht, R.; Baghai, T.C. Neurobiology of depression: A neurodevelopmental approach. World J. Biol. Psychiatry 2018, 19, 349–359. https://doi.org/10.1080/15622975.2017.1289240.
• 5.
  Maj, M.; Stein, D.J.; Parker, G.; et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry 2020, 19, 269–293. https://doi.org/10.1002/wps.20771.
• 6.
  McIntyre, R.S.; Alsuwaidan, M.; Baune, B.T.; et al. Treatment-resistant depression: Definition, prevalence, detection, management, and investigational interventions. World Psychiatry 2023, 22, 394–412. https://doi.org/10.1002/wps.21120.
• 7.
  Volkow, N.D.; Blanco, C. Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry 2023, 22, 203–229. https://doi.org/10.1002/wps.21073.
• 8.
  Schifano, F.; Napoletano, F.; Chiappini, S.; et al. New/emerging psychoactive substances and associated psychopathological consequences. Psychol. Med. 2021, 51, 30–42. https://doi.org/10.1017/S0033291719001727. Erratum in: Psychol. Med. 2021, 51, 43. https://doi.org/10.1017/S003329171900254X.
• 9.
  Sampogna, G.; Toni, C.; Catapano, P.; et al. New trends in personalized treatment of depression. Curr. Opin. Psychiatry 2024, 37, 3–8. https://doi.org/10.1097/YCO.0000000000000903.